The company said April 21 that its diluted earnings per share were $2.92, down 15.6 percent from 2021. Excluding COVID-19 testing, the company pulled in $2.01 billion, up more than six percent year-over-year.
COVID-19 testing revenues fell from $828 million in the first quarter of 2021 to $599 million in the first quarter of 2022, a drop of 27.6 percent.
Quest now expects its full year 2022 net revenue to land between $9.2 billion and $9.5 billion, with a per-share earning between $7.88 and $8.38.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.